Authors: MCSHEFFREY JB MPOFU C MAKSYMIUK A LI XM TAN L ALI SK

Citation: Jb. Mcsheffrey et al., NEGATIVE MINIMAL RESIDUAL DISEASE AT THE END OF INDUCTION IDENTIFIES PATIENTS WITH GOOD PROGNOSIS IN CHILDHOOD B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA, Clinical chemistry, 44, 1998, pp. 131-131

Authors: KOBRINSKY NL HARTFIELD D HORNER H MAKSYMIUK A MINUK GY WHITE DF FELDSTEIN TJ

Citation: Nl. Kobrinsky et al., TREATMENT OF ADVANCED MALIGNANCIES WITH HIGH-DOSE ACETAMINOPHEN AND N-ACETYLCYSTEINE RESCUE, Cancer investigation, 14(3), 1996, pp. 202-210

Authors: LATREILLE J LABERGE F VIALLET J MAKSYMIUK A SHEPHERD F GELMAN K DELORME F

Citation: J. Latreille et al., PHASE-II TRIAL WITH DOCETAXEL IN PATIENTS (PTS) WITH NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1070-1070

Authors: XIANG J MOYANA T MAKSYMIUK A

Citation: J. Xiang et al., AUTOLOGOUS HUMAN B-CELL IMMUNE-RESPONSE TO PULMONARY ADENOCARCINOMATOUS POLYMORPHIC EPITHELIAL MUCIN, Journal of clinical immunology, 15(2), 1995, pp. 74-79